check_circleStudy Completed

Erythrasma

Bayer Identifier:

Trial_0413

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Efficacy (clinical and bacteriological) and tolerance of bifonazole cream 1% in the treatment of erythrasma

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

15 - 70 Years
  • -

  • -

Trial summary

Enrollment Goal
30
Trial Dates
March 1986 - January 1987
Phase
N/A
Could I Receive a placebo
N/A
Products
Mycospor/Canesten Extra (Bifonazole, BAYH4502)
Accepts Healthy Volunteer
N/A

Trial design

Open label, prospective study to evaluate the efficacy (clinical and bacteriological) and tolerance of bifonazole cream 1% in the treatment of erythrasma
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.